Safety and Efficacy of Repeated Administrations of NurOwn® in ALS Patients

NCT03280056 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

196

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis (ALS)

Interventions

BIOLOGICAL: NurOwn® (MSC-NTF cells)
OTHER: Placebo
OTHER: Bone Marrow aspiration

Sponsor

Brainstorm-Cell Therapeutics

Collaborators

[object Object]